The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice

European Journal of Neuroscience

Volumn 19, Issue 9, 2004, Pages 2561-2568

  Thompson, Barbara E ^a   Sachs, Benjamin D ^a   Kantak, Kathleen M ^a   Cherry, James A ^a  

^a Department of Psychology ^*  (United States)

Author keywords

Accumbens; Addiction; C fos; Cyclic AMP; Food; Morphine; Reward; Striatum

Indexed keywords

COCAINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; MORPHINE; PHOSPHODIESTERASE IV INHIBITOR; PROTEIN C FOS; ROLIPRAM DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FOOD PREFERENCE; GENE INDUCTION; IMMEDIATE EARLY GENE; INSTRUMENTAL CONDITIONING; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REWARD; SINGLE DRUG DOSE;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; BASAL GANGLIA; CELL COUNT; COCAINE; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GENE EXPRESSION REGULATION; MALE; MICE; MORPHINE; PHOSPHODIESTERASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-FOS; ROLIPRAM;

EID: 2442612952     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0953-816X.2004.03357.x     Document Type: Article

References (60)

1. Allan, A.M., Galindo, R., Chynoweth, J., Engel, S.R. & Savage, D.D. (2001) Conditioned place preference for cocaine is attenuated in mice over-expressing the 5-HT(3) receptor. Psychopharmacology (Berl.), 158, 18-27.
2. Bach, M.E., Barad, M., Son, H., Zhuo, M., Lu, Y.F., Shih, R., Mansuy, I., Hawkins, R.D. & Kandel, E.R. (1999) Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway. Proc. Natl Acad. Sci. USA, 96, 5280-5285.
3. Barad, M., Bourtchouladze, R., Winder, D.G., Golan, H. & Kandel, E. (1998) Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proc. Natl Acad. Sci. USA, 95, 15020-15025.
4. Bardo, M.T. & Bevins, R.A. (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl.), 153, 31-43.
5. Barrot, M., Olivier, J.D., Perrotti, L.I., DiLeone, R.J., Berton, O., Eisch, A.J., Impey, S., Storm, D.R., Neve, R.L., Yin, J.C., Zachariou, V. & Nestler, E.J. (2002) CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc. Natl Acad. Sci. USA, 99, 11435-11440.
6. Becker, A., Grecksch, G., Kraus, J., Loh, H.H., Schroeder, H. & Hollt, V. (2002) Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice. Naunyn Schmiedebergs Arch. Pharmacol., 365, 296-302.
7. Carlezon, W.A. Jr, Thome, J., Olson, V.G., Lane-Ladd, S.B., Brodkin, E.S., Hiroi, N., Duman, R.S., Neve, R.L. & Nestler, E.J. (1998) Regulation of cocaine reward by CREB. Science, 282, 2272-2275.
8. Castanon, N., Scearce-Levie, K., Lucas, J.J., Rocha, B. & Hen, R. (2000) Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knockouts and antagonists. Pharmacol. Biochem. Behav., 67, 559-566.
9. Cherry, J.A. & Davis, R.L. (1999) Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J. Comp. Neurol., 407, 287-301.
10. Conti, M., Richter, W., Mehats, C., Livera, G., Park, J.Y. & Jin, C. (2003) Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J. Biol. Chem., 278, 5493-5496.
11. Corrigall, W.A. & Coen, K.M. (1991) Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology (Berl.), 104, 167-170.
12. Drago, J., Gerfen, C.R., Westphal, H. & Steiner, H. (1996) D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum. Neuroscience, 74, 813-823.
13. Dudai, Y., Jan, Y.N., Byers, D., Quinn, W.G. & Benzer, S. (1976) Dunce, a mutant of Drosophila deficient in learning. Proc. Natl Acad. Sci. USA, 73, 1684-1688.
14. Fleischhacker, W.W., Hinterhuber, H., Bauer, H., Pflug, B., Berner, P., Simhandl, C., Wolf, R., Gerlach, W., Jaklitsch, H., Sastre-y-Hernandez, M., Schmeding-Wiegel, H., Sperner-Unterweger, B., Voet, B. & Schubert, H. (1992) A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder. Neuropsychobiology, 26, 59-64.
15. Franklin, K.B.J. & Paxinos, G. (1997) The Mouse Brain in Stereotaxic Coordinates, Academic Press, San Diego.
16. Graybiel, A.M., Moratalla, R. & Robertson, H.A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl Acad. Sci. USA, 87, 6912-6916.
17. Hamdy, M.M., Mamiya, T., Noda, Y., Sayed, M., Assi, A.A., Gomaa, A., Yamada, K. & Nabeshima, T. (2001) A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice. Behav. Brain Res., 118, 85-93.
18. Harlan, R.E. & Garcia, M.M. (1998) Drugs of abuse and immediate-early genes in the forebrain. Mol. Neurobiol., 16, 221-267.
19. Houslay, M.D. & Adams, D.R. (2003) PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem. J., 370, 1-18.
20. Itoh, A., Noda, Y., Mamiya, T., Hasegawa, T. & Nabeshima, T. (1998) A therapeutic strategy to prevent morphine dependence and tolerance by coadministration of cAMP-related reagents with morphine. Meth. Find. Exp. Clin. Pharmacol., 20, 619-625.
21. Iyo, M., Bi, Y., Hashimoto, K., Inada, T. & Fukui, S. (1996) Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram. Eur. J. Pharmacol., 312, 163-170.
22. Kim, D.S., Froelick, G.J. & Palmiter, R.D. (2002) Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum. J. Neurosci., 22, 9841-9849.
23. Kim, H.S., Park, W.K., Jang, C.G. & Oh, S. (1996) Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice. Brain Res. Bull., 40, 201-207.
24. Knapp, C.M., Foye, M.M., Ciraulo, D.A. & Kornetsky, C. (1999) The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration. Pharmacol. Biochem. Behav., 62, 151-158.
25. Krause, W. & Kuhne, G. (1988) Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the rat and the rabbit. Studies on species differences. Xenobiotica, 18, 561-571.
26. Lawley, S.I. & Kantak, K.M. (1990) Postconditioning effects of magnesium on cocaine conditioned place preference in mice. Pharmacol. Biochem. Behav., 36, 531-538.
27. Lucas, J.J., Segu, L. & Hen, R. (1997) 5-Hydroxytryptamine1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-hydroxytryptamine1B knockout mice and the 5- hydroxytryptamine1B/1D antagonist GR127935. Mol. Pharmacol., 51, 755-763.
28. Maldonado, R., Saiardi, A., Valverde, O., Samad, T.A., Roques, B.P. & Borrelli, E. (1997) Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature, 388, 586-589.
29. Mamiya, T., Noda, Y., Ren, X., Hamdy, M., Furukawa, S., Kameyama, T., Yamada, K. & Nabeshima, T. (2001) Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor. Br. J. Pharmacol., 132, 1111-1117.
30. Manzanedo, C., Aguilar, M.A., Rodriguez-Arias, M. & Minarro, J. (2001) Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice. Behav. Brain Res., 121, 189-197.
31. Moratalla, R., Xu, M., Tonegawa, S. & Graybiel, A.M. (1996) Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc. Natl Acad. Sci. USA, 93, 14928-14933.
32. Mon, T., Baba, J., Ichimaru, Y. & Suzuki, T. (2000) Effects of rolipram, a selective inhibitor of phosphodiesterase 4, on hyperlocomotion induced by several abused drugs in mice. Jpn J. Pharmacol., 83, 113-118.
33. Nagakura, A., Niimura, M. & Takeo, S. (2002) Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats. Br. J. Pharmacol., 135, 1783-1793.
34. Nestler, E.J. (1996) Under siege: The brain on opiates. Neuron, 16, 897-900.
35. Nestler, E.J. (2001) Molecular neurobiology of addiction. Am. J. Addict., 10, 201-217.
36. O'Donnell, J.M. & Frith, S. (1999) Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases. Pharmacol. Biochem. Behav., 63, 185-192.
37. Porrino, L.J. & Lyons, D. (2000) Orbital and medial prefrontal cortex and psychostimulant abuse: studies in animal models. Cereb. Cortex, 10, 326-333.
38. Rademacher, D.J. & Steinpreis, R.E. (2002) Effects of the selective mu(1)-opioid receptor antagonist, naloxonazine, on cocaine-induced conditioned place preference and locomotor behavior in rats. Neurosci. Lett., 332, 159-162.
39. Raymond, J.R., Mukhin, Y.V., Gelasco, A., Turner, J., Collinsworth, G., Gettys, T.W., Grewal, J.S. & Garnovskaya, M.N. (2001) Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol. Ther., 92, 179-212.
40. Robertson, G.S. & Jian, M. (1995) D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain. Neuroscience, 64, 1019-1034.
41. Sasaki, H., Hashimoto, K., Maeda, Y., Inada, T., Kitao, Y., Fukui, S. & Iyo, M. (1995) Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in rats. Life Sci., 56, PL443-447.
42. Schneider, H.H. (1984) Brain cAMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation. Biochem. Pharmacol., 33, 1690-1693.
43. Schwabe, U., Miyake, M., Ohga, Y. & Daly, J.W. (1976) 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic-3′,5′-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain. Mol. Pharmacol., 12, 900-910.
44. Scott, A.I., Perini, A.F., Shering, P.A. & Whalley, L.J. (1991) In-patient major depression: is rolipram as effective as amitriptyline? Eur. J. Clin. Pharmacol., 40, 127-129.
45. Self, D.W., Genova, L.M., Hope, B.T., Barnhart, W.J., Spencer, J.J. & Nestler, E.J. (1998) Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J. Neurosci., 18, 1848-1859.
46. Self, D.W., Terwilliger, R.Z., Nestler, E.J. & Stein, L. (1994) Inactivation of Gi and G(o) proteins in nucleus accumbens reduces both cocaine and heroin reinforcement. J. Neurosci., 14, 6239-6247.
47. Smith, J.W., Fetsko, L.A., Xu, R. & Wang, Y. (2002) Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning. Neuroscience, 113, 755-765.
48. Steketee, J.D. (2003) Neurotransmitter systems of the medial prefrontal cortex; potential role in sensitization to psychostimulants. Brain Res. Brain Res. Rev., 41, 203-228.
49. Svenningsson, P., Johansson, B. & Fredholm, B.B. (1995) Effect of different xanthines and phosphodiesterase inhibitors on c-fos expression in rat striatum. Acta Physiol. Scand., 154, 17-24.
50. Torres, G. & Horowitz, J.M. (1999) Drugs of abuse and brain gene expression. Psychosom. Med., 61, 630-650.
51. Trinh, J.V., Nehrenberg, D.L., Jacobsen, J.P., Caron, M.G. & Wetsel, W.C. (2003) Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice. Neuroscience, 118, 297-310.
52. Tzschentke, T.M. (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol., 56, 613-672.
53. Valjent, E., Corvol, J.C., Pages, C., Besson, M.J., Maldonado, R. & Caboche, J. (2000) Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci., 20, 8701-8709.
54. Wachtel, H. (1983a) Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors. Neuropharmacology, 22, 267-272.
55. Wachtel, H. (1983b) Species differences in behavioural effects of rolipram and other adenosine cyclic 3H, 5H-monophosphate phosphodiesterase inhibitors. J. Neural. Transm., 56, 139-152.
56. Wise, R.A. (1998) Drug-activation of brain reward pathways. Drug Alcohol Depend., 51, 13-22.
57. Young, S.T., Porrino, L.J. & Iadarola, M.J. (1991) Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl Acad. Sci. USA, 88, 1291-1295.
58. Zhang, H.T., Crissman, A.M., Dorairaj, N.R., Chandler, L.J. & O'Donnell, J.M. (2000) Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism. Neuropsychopharmacology, 23, 198-204.
59. Zhang, D., Zhang, L., Lou, D.W., Nakabeppu, Y., Zhang, J. & Xu, M. (2002) The dopamine D1 receptor is a critical mediator for cocaine-induced gene expression. J. Neurochem., 82, 1453-1464.
60. Zhuang, X., Belluscio, L. & Hen, R. (2000) G(olf)alpha mediates dopamine D1 receptor signaling. J. Neurosci., 20, RC91.